The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 237 of the 241 references it cites were found in a registry or an index.
Abstract
Objective: To develop clinical practice guidelines for the management of patients with primary aldosteronism. Participants: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration. Evidence: We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations. Consensus Process: We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes. Conclusions: For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the detection, confirmation, subtype testing, and treatment of PA. a We recommend unilateral laparoscopic adrenalectomy for patients with documented unilateral PA (ie, APA or UAH) (1 ⎪ QQQE ). If a patient is unable or unwilling to undergo surgery, we recommend medical treatment including a MR antagonist (1 ⎪ QQQE ). If an ARR-positive patient is unwilling or unable to undergo further investigations, we similarly recommend medical treatment including an MR antagonist (1 ⎪ QQEE ). b Instead of proceeding directly to subtype classification, we recommend that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1 ⎪ QQEE ). However, in the setting of spontaneous hypokalemia, undetectable renin, and PAC > 20 ng/dL (550 pmol/L), we suggest that there may be no need for further confirmatory testing (2 ⎪ QEEE ). c We recommend that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use AVS to make the distinction between unilateral and bilateral adrenal disease (1 ⎪ QQQE ). Younger patients ( < age 35) with spontaneous hypokalemia, marked aldosterone excess, and unilateral adrenal lesions with radiological features consistent with a cortical adenoma on adrenal CT scan may not need AVS before proceeding to unilateral adrenalectomy (2 ⎪ QEEE ). [Adapted from J. W. Funder et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab . 2008;93:3266-3281 (3), with permission. © Endocrine Society.]](https://figures.cochat.ai/paper-figures/aaade82f5c4b425bbdee69e74321806d/the-management-of-primary-aldosteronism-case-detection-diagnosis-and-treatment-figure-1.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common types of secondary hypertension in adults are renal parenchymal disease, renovascular hypertension, primary aldosteronism, chronic sleep apnea, and substance/drug-induced.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A specific cause of secondary hypertension can be identified in 5%-10% of hypertensive patients (Table 11).”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypokalemia, which reduces aldosterone secretion, should be corrected with oral K+ supplements before testing.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with unilateral disease (50%; aldosterone-producing adenoma or, much less frequently, unilateral hyperplasia) respond to unilateral laparoscopic adrenalectomy with complete cure (≈50%) or improvement (≈50%) in BP control.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation group, an international group with expertise in the development and implementation of evidence-based guidelines (2).”
MethodNational High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554 · cited 3×
“The recommendations and suggestions made by the Task Force were subject to extensive consultation before being published in the Journal of Clinical Endocrinology and Metabolism in 2008 (3).”
MethodSelf-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547 · cited 2×
“Several outcome studies also have provided evidence that PA patients are particularly at risk of cardiovascular/ renal complications, including arrhythmias, myocardial infarction, strokes, chronic kidney disease, and death, compared with age-, sex-, and BP-matched essential hypertensives (30, 33, 156).”
BackgroundResultA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467 · cited 2×
“However, some groups have suggested that when clinicians administer a bolus injection of cosyntropin and sample the adrenal veins simultaneously, cosyntropin does not improve the diagnostic accuracy of AVS, and, in fact, cosyntropin may increase secretion from the nonadenomatous gland to a greater degree than from the…”
BackgroundSelf-citation
Research works printed but not linked: 3
- 15. Tucker RM, Labarthe DR. Frequency of surgical treatment for hypertensioninadultsattheMayoClinicfrom1973through1975. Mayo Clin Proc . 1977;52:549-545.
- 133. FardellaCE,PintoM,MossoL,Gómez-SánchezC,JalilJ,Montero J. Genetic study of patients with dexamethasone-suppressible aldosteronismwithoutthechimericCYP11B1/CYP11B2gene. J Clin Endocrinol Metab . 2001;86:4805-4807.
- 169. Jacobsen NE, Campbell JB, Hobart MG. Laparoscopic versus openadrenalectomyforsurgicaladrenaldisease. CanJUrol . 2003; 10:1995-1999.
Cited by
Items 301–400 of 1,002
Akasaka, H., Yamamoto, K. I., Rakugi, H., Nagasawa, M., Nakamaru, R., Ichijo, T., Takeda, Y., Kurihara, I., Katabami, T., Tsuiki, M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13006 · Cited by 42
“However, when the PA is classified as unilateral in adrenal vein sampling (AVS), adrenalectomy is indicated.(2,3,6) As AVS is an invasive, time-consuming procedure, several methods of predicting nonunilateral (bilateral) PA by using scoring systems have been proposed to avoid unnecessary AVS in patients without an ind…”
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism
Yang, Y., Reincke, M., & Williams, T. A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101365 · Cited by 44
Self-citationHypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism
McCarthy, J., Yang, J., Clissold, B. G., Young, M. J., Fuller, P. J., & Phan, T. G. (2021) · Stroke · doi:10.1161/strokeaha.120.033990 · Cited by 47
Kim, B., Kwak, M. K., Ahn, S. H., Kim, H., Lee, S. H., & Koh, J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02043 · Cited by 43
“Primary aldosteronism (PA) is a disorder of the adrenal gland characterized by the autonomous hypersecretion of aldosterone and is the most common cause of secondary hypertension, accounting for 5% to 10% of all patients with hypertension (8, 9).”
BackgroundMethodInfluentialConfirmatory Testing for Primary Aldosteronism: A Study of Diagnostic Test Accuracy
Leung, A. A. C., Padwal, R. S., Hundemer, G. L., Venos, E., Campbell, D. J. T., Holmes, D. T., Orton, D. J., So, B., Przybojewski, S. J., Caughlin, C. E., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-03153 · Cited by 41
Reincke, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02141 · Cited by 40
“Since cardiovascular and renal outcomes seem to be similar between surgical and medical treatment (11) quality of life might become the only justification for surgery.”
Self-citationSubtyping of Patients with Primary Aldosteronism: An Update
Lenders, J. W. M., Eisenhofer, G., & Reincke, M. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122602 · Cited by 41
“84 Subsequently MRI has provided an alternative anatomical imaging modality but apart from lack of 85 radiation exposure carries no advantages over CT for subtyping PA patients [6].”
InfluentialSelf-citationIs it time to screen all patients with hypertension for primary aldosteronism?
Yang, J., Fuller, P. J., & Stowasser, M. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00783 · Cited by 42
Self-citationAdrenal Venous Sampling With or Without Adrenocorticotropic Hormone Stimulation: A Meta-Analysis
Laurent, I., Manirakiza, A., Zheng, F., Chen, X., Yang, J., Cheng, Q., & Li, Q. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01324 · Cited by 41
Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and meta‐analysis
Wu, S., Yang, J., Hu, J., Song, Y., He, W., Yang, S., Luo, R., & Li, Q. (2019) · Clinical Endocrinology · doi:10.1111/cen.13943 · Cited by 46
Ohno, Y., Naruse, M., Beuschlein, F., Schreiner, F., Parasiliti‐Caprino, M., Deinum, J., Drake, W. M., Fallo, F., Fuß, C. T., Grytaas, M. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa706 · Cited by 42
Self-citationEndocrine Causes of Hypertension
de Silva, T., Cosentino, G., Ganji, S. S., Riera-Gonzalez, A., & Hsia, D. S. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01108-3 · Cited by 44
Funder, J. W. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.03.005 · Cited by 42
Self-citationWhat Is the Most Common Cause of Secondary Hypertension?: An Interdisciplinary Discussion
Almeida, M. Q., da Silva, G. V., & Drager, L. F. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01106-5 · Cited by 47
Puar, T. H. K., Khoo, C. M., Tan, C. J., Tong, A. K. T., Tan, M. C. S., Teo, A. E. D., Ng, K. S., Wong, K. M., Reilhac, A., O’Doherty, J., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003132 · Cited by 42
“Our AVS lateralization ratio threshold is consistent with current guidelines [3,8], and five of our patients cured of primary aldosteronism post-surgery had ratios below this threshold.”
BackgroundResultMulatero, P., Scholl, U. I., Fardella, C., Charmandari, E., Januszewicz, A., Reincke, M., Gómez-Sánchez, C. E., Stowasser, M., & Dekkers, O. M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae041 · Cited by 46
Self-citationHypomethylation of CYP11B2 in Aldosterone-Producing Adenoma
Yoshii, Y., Oki, K., Gómez-Sánchez, C. E., Ohno, H., Itcho, K., Kobuke, K., & Yoneda, M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08313 · Cited by 40
“The 2 most common forms of PA are aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism, also called as bilateral adrenal zona glomerulosa hyperplasia.(1) Aldosterone is produced from the precursor cholesterol via a series of steroidogenic enzymes, and APA has higher levels of aldosterone synthase (CYP…”
BackgroundOld and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Prada, E. T. A., Burrello, J., Reincke, M., & Williams, T. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10111 · Cited by 39
Self-citationMeng, X., Li, Y., Wang, X., Li, J., Liu, Y., & Yu, Y. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01530 · Cited by 41
Postoperative Complications Associated with External Skeletal Fixators in Dogs
Giles, K., Meeson, R., & Beever, L. (2018) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.1055/s-0038-1627477 · Cited by 41
THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism
Lechner, B., Lechner, K., Heinrich, D., Adolf, C., Holler, F., Schneider, H., Beuschlein, F., & Reincke, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0215 · Cited by 40
Self-citationZhou, Y., Wang, D., Jiang, L., Ran, F., Chen, S., Zhou, P., & Wang, P. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038489 · Cited by 40
Seidel, E., Schewe, J., Zhang, J., Dinh, H. A., Forslund, S. K., Markó, L., Hellmig, N., Peters, J., Müller, D. N., Lifton, R. P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014876118 · Cited by 40
“Its diagnosis is based on an elevated aldosterone:renin ratio (ARR) and a positive confirmatory test, such as the failure to suppress aldosterone levels upon administration of NaCl ( “ saline suppression test ” ) (4).”
Takeda, Y., Umakoshi, H., Takeda, Y., Yoneda, T., Kurihara, I., Katabami, T., Ichijo, T., Wada, N., Yoshimoto, T., Ogawa, Y., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001964 · Cited by 39
Self-citationDaily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Albiger, N., Antonelli, G., Zilio, M., Todeschini, M., Regazzo, D., Plebani, M., Lacognata, C., Iacobone, M., et al. (2018) · Endocrine · doi:10.1007/s12020-017-1421-3 · Cited by 38
Self-citationDogra, P., Šambula, L., Saini, J., Thangamuthu, K., Athimulam, S., Delivanis, D. A., Baikousi, D. A., Nathani, R., Zhang, C. D., Genere, N., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad113 · Cited by 38
Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection
Hernandez, M. R. F., & Bhalla, V. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.01.447 · Cited by 43
Current pattern of primary aldosteronism diagnosis: Delayed and complicated
Lim, Y. Y., Shen, J., Fuller, P. J., & Yang, J. (2018) · Australian Journal of General Practice · doi:10.31128/ajgp-05-18-4587 · Cited by 38
Drug-induced endocrine blood pressure elevation
Beck, K. R., Thompson, G. R., & Odermatt, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104311 · Cited by 42
Wolley, M. J., Thuzar, M., & Stowasser, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101400 · Cited by 41
Self-citationMolecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 40
“However, current guidelines for diagnosis of PA do not indicate hypercortisolism assessment [142].”
BackgroundRossi, G. P., Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., Deinum, J., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa108 · Cited by 40
“What was unexpected was to discover that about half of the patients had RH by the managing physician’s definition, i.e. RHlocal, which indicates overestimation of RH, as compared to a structured guidelines-based AHA 2018 definition.4 This could have occurred either because the data collected in the predefined form of…”
BackgroundInfluentialSelf-citationZhu, Q., Heizhati, M., Lin, M., Wang, M., Yao, X., Gan, L., Luo, Q., Zhang, W., Hong, J., Yue, N., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18342 · Cited by 38
Maciel, A. A. W., Freitas, T. C., Fagundes, G. F. C., Petenuci, J., Vilela, L. A. P., Brito, L. P., Goldbaum, T. S., Zerbini, M. C. N., Ledesma, F. L., Tanno, F. Y., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac679 · Cited by 43
International multicenter survey on screening and confirmatory testing in primary aldosteronism
Naruse, M., Murakami, M., Katabami, T., Kocjan, T., Parasiliti‐Caprino, M., Quinkler, M. O., St‐Jean, M., O’Toole, S. M., Ceccato, F., Kraljević, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac002 · Cited by 40
KCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension
Manichaikul, A. W., Rich, S. S., Allison, M., Guagliardo, N. A., Bayliss, D. A., Carey, R. M., & Barrett, P. Q. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07564 · Cited by 41
“A substantial body of clinical and experimental data implicates aldosterone in the pathogenesis of hypertension, the prime example of which is primary aldosteronism, the most common secondary hypertensive disorder.(18,19) Moreover, additional evidence in support of a relationship between circulating aldosterone and hy…”
BackgroundSelf-citationAldosterone Induces Vascular Damage: A Wave Reflection Analysis Study
Hung, C., Sung, S., Liao, C., Pan, C., Chang, C., Chen, Z., Wu, V., Chen, C., Cheng, H., Lin, Y., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12342 · Cited by 39
Role of the endothelium and blood stasis in the development of varicose veins.
Michiels, C., Bouaziz, N., & Remacle, J. (2002) · PubMed · Cited by 49
Zhu, L., Zhang, Y., Zhang, H., Zhou, W., Shen, Z., Zheng, F., Tang, X., Tao, B., Zhang, J., Lu, X., et al. (2016) · Medicine · doi:10.1097/md.0000000000004986 · Cited by 38
“Hypertension was considered cured if systolic/diastolic blood pressure (BP) was controlled ( 140/90mmHg) without medication and improved if BP was controlled with a reduced number of antihypertensive drugs.”
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Kramer, H., Townsend, R. R., Griffin, K. A., Flynn, J. T., Weiner, D. E., Rocco, M. V., Choi, M. J., Weir, M. R., Chang, T. I., Agarwal, R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.01.007 · Cited by 39
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 47
Castro, M. A., Paja, M., Boillos, M. G., Peris, B. P., Corrales, E. P., Cano, A. M. G., Ramírez, P. A. P., Rojas‐Marcos, P. M., Ruiz-Sánchez, J. G., Delgado, A. V., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03122-8 · Cited by 39
Maiolino, G., Ceolotto, G., Battistel, M., Barbiero, G., Cesari, M., Amar, L., Caroccia, B., Padrini, R., Azizi, M., & Rossi, G. P. (2018) · Blood Pressure · doi:10.1080/08037051.2018.1436961 · Cited by 38
“Study A: Consecutive hypertensive patients of both sexes with PA, who according to current guidelines [13] must be subtyped by AVS before being referred”
BackgroundUmakoshi, H., Tsuiki, M., Yokomoto‐Umakoshi, M., Takeda, Y., Takashi, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00055 · Cited by 42
“4 recommended by clinical guidelines [5] may be appropriate for determining unilateral disease in PA.”
BackgroundMethodSelf-citationSFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing
Reznik, Y., Amar, L., & Tabarin, A. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.007 · Cited by 42
Yamazaki, Y., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Adachi, Y., Ise, K., Nakamura, Y., Gómez-Sánchez, C. E., Shibahara, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10907 · Cited by 37
Pediatric adrenocortical tumor – review and management update
Balderrama-Brondani, V., & Fragoso, M. C. B. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000540 · Cited by 38
Kaneko, H., Umakoshi, H., Ogata, M., Wada, N., Iwahashi, N., Fukumoto, T., Yokomoto‐Umakoshi, M., Nakano, Y., Matsuda, Y., Miyazawa, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88712-8 · Cited by 37
Rossi, G. P., Crimì, F., Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab482 · Cited by 38
Self-citationChu, L., Fuller, M. T., Jervis, K., Ciaccia, A., & Abitbol, A. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.07.015 · Cited by 43
Tsai, C., Liao, C., Wu, X.-M., Chen, Z., Pan, C., Chang, Y., Lee, B., Shun, C., Wen, W.-F., Chou, C., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1157 · Cited by 38
“APA was diagnosed in patients with PA and at least one of the three following conditions: (1) adenoma on a computed tomography (CT) scan for preoperative evaluation; (2) lateralization of APA was examined by adrenal vein sampling or dexamethasone suppression adrenocortical scintigraphy (NP-59 SPECT/CT); and (3) pathol…”
BackgroundMethodInfluentialApproach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism
Mulatero, P., Bertello, C., Veglio, F., & Monticone, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac460 · Cited by 38
Cohen, J. B., Bancos, I., Brown, J. M., Sarathy, H., Turcu, A. F., & Cohen, D. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-100438 · Cited by 38
Rossitto, G., Battistel, M., Barbiero, G., Bisogni, V., Maiolino, G., Miotto, D., Seccia, T. M., & Rossi, G. P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001564 · Cited by 37
Wang, S., Chen, S., Gao, W., Bai, L., Luo, L., Zheng, X.-G., & Luo, Y. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.10.2817 · Cited by 39
“Therefore, open adrenalectomy was recommended in the guidelines (Funder et al., 2016; Stigliano et al., 2016), but not all studies were consistent (Lombardi et al., 2012; Fossa et al., 2013; Donatini et al., 2014).”
BackgroundGenetic Characterization of GnRH/LH-Responsive Primary Aldosteronism
Gagnon, N., Caceres, K., Corbeil, G., Ghoyareb, N. E., Ludwig, N. G., Latour, M., Lacroix, A., & Bourdeau, I. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00087 · Cited by 36
Gong, S., Sun, N., Meyer, L. S., Tetti, M., Koupourtidou, C., Krebs, S., Masserdotti, G., Blum, H., Rainey, W. E., Reincke, M., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20921 · Cited by 36
Self-citationGoodchild, E., Wu, X., Senanayake, R., MacFarlane, J., Argentesi, G., Laycock, K., Bashari, W. A., Cabrera, C., O’Toole, S. M., Salsbury, J., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-00761 · Cited by 37
“The Endocrine Society guideline captures clinical practice over many decades in recommending adrenal-ectomy for unilateral PA (4).”
Page, M. M., Taranto, M., Ramsay, D. W., van Schie, G., Glendenning, P., Gillett, M. J., & Vasikaran, S. D. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218760352 · Cited by 37
“Despite this, successful bilateral cannulation is reported in about 60–70% of cases in many centres.(2,3) Venography is inaccurate for determining successful cannulation of the adrenal veins.”
BackgroundInfluentialRadiation exposure of adrenal vein sampling: a German Multicenter Study
Fuss, C. T., Treitl, M., Rayes, N., Podrabsky, P., Fenske, W. K., Heinrich, D. A., Reincke, M., Petersen, T., Faßnacht, M., Quinkler, M. O., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0328 · Cited by 40
Self-citationRossi, G. P., Maiolino, G., & Seccia, T. M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.012 · Cited by 35
“Therefore, in line with the global experience, to distinguish between unilateral and bilateral aldosterone excess, the US Endocrine Society and the Japan Endocrine Society guidelines recommend that AVS be offered to all patients with an unequivocal diagnosis of PA who want to pursue surgical cure.(5,6) For a more in-d…”
BackgroundAldosterone-potassium ratio predicts primary aldosteronism subtype
Puar, T. H. K., Loh, W. J., Lim, D. S. T., Loh, L. M., Zhang, M., Foo, R., Lee, L. M. Y., Swee, D. S., Khoo, J. J. C., Tay, D., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002348 · Cited by 38
“A bout 50% of patients with primary aldosteronism have unilateral disease and can be cured with laparoscopic adrenalectomy [1,2].”
BackgroundMethodInfluentialCastro, M. A., Valderrábano, P., Escobar-Morreale, H. F., Hanzu, F. A., & Casals, G. (2020) · Endocrine · doi:10.1007/s12020-020-02544-6 · Cited by 36
Ozeki, Y., Tanimura, Y., Nagai, S., Nomura, T., Kinoshita, M., Shibuta, K., Matsuda, N., Miyamoto, S., Yoshida, Y., Okamoto, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030433 · Cited by 35
“Subsequently, we performed an oral sodium loading test (OSLT), captopril challenge test (CCT), saline infusion test (SIT), and furosemide upright posture test to confirm or exclude the diagnosis of PA [2,6,8,11,12].”
MethodSelf-citationFrequently asked questions and answers (if any) in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01615-3 · Cited by 38
Role of α1‐blockers in the current management of hypertension
Li, H., Xu, T., Li, Y., Chia, Y. C., Buranakitjaroen, P., Cheng, H., Minh, H. V., Sogunuru, G. P., Tay, J. C., Wang, T., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14556 · Cited by 39
Buffolo, F., Pieroni, J., Ponzetto, F., Forestiero, V., Rossato, D., Fonio, P., Nonnato, A., Settanni, F., Mulatero, P., Mengozzi, G., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad179 · Cited by 35
Detection and location of the enzymes of de novo pyrimidine biosynthesis in mammalian spermatozoa
Carrey, E. A., Dietz, C., Glubb, D. M., Löffler, M., Lucocq, J. M., & Watson, P. F. (2002) · Reproduction · doi:10.1530/rep.0.1230757 · Cited by 40
Rossi, G. P., & Funder, J. W. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08820 · Cited by 35
Self-citationSong, S., Cai, X., Hu, J., Zhu, Q., Shen, D., Heizhati, M., Yang, W., Hong, J., & Li, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1373862 · Cited by 35
Argentesi, G., Wu, X., Ney, A., Goodchild, E., Laycock, K., Lee, Y.-N., Senanayake, R., MacFarlane, J., Ng, E., Kearney, J., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02755-7 · Cited by 35
Holmqvist, L. D., Boström, K. B., Kahan, T., Schiöler, L., Hasselström, J., Hjerpe, P., Wettermark, B., & Manhem, K. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001561 · Cited by 37
“patients with TRH might have a high degree of undiagnosed primary aldosteronism, a condition with high prevalence in hypertensive patients, particularly in TRH [26], and excess aldosterone levels, which stimulates myocardial fibrosis beyond the effects of BP level [27].”
BackgroundMouse Models of Primary Aldosteronism: From Physiology to Pathophysiology
Santiago, L. A., Gómez-Sánchez, C. E., Mulatero, P., Spyroglou, A., Reincke, M., & Williams, T. A. (2017) · Endocrinology · doi:10.1210/en.2017-00637 · Cited by 35
Self-citationEvaluation and Management of Primary Hyperaldosteronism
Lee, F. T., & Elaraj, D. M. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.010 · Cited by 44
Yoshida, S., Kurajoh, M., Fukumoto, S., Murase, T., Nakamura, T., Yoshida, H., Hirata, K., Inaba, M., & Emoto, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61463-8 · Cited by 37
Yang, Y., Williams, T. A., Song, Y., Yang, S., He, W., Wang, K., Cheng, Q., Ma, L., Luo, T., Yang, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa634 · Cited by 34
Self-citationYozamp, N. S., Hundemer, G. L., Moussa, M., Underhill, J., Fudim, T., Sacks, B. A., & Vaidya, A. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17248 · Cited by 36
How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 42
“Primary aldosteronism is rare in ACC and is usually accompanied by severe hypokalemia, whereas the production of androgens, resulting in virilization, and estrogen evidently point towards malignancy in adrenocortical tumors [42].”
BackgroundQiu, J., Li, N., Xiong, H., Yang, J., Li, Y.-D., Hu, C., Lai, Z.-Q., Liang, N., Zhang, H., Jiang, X., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01236-8 · Cited by 34
“In contrast, lifelong MR antagonists, alone or in combination with other agents, are recommended for treatment in patients who are identified as PA without lateralized secretion of aldosterone (bilateral PA) on AVS [2, 3].”
BackgroundMethodInfluentialTargeted Molecular Imaging in Adrenal Disease—An Emerging Role for Metomidate PET-CT
Mendichovszky, I. A., Powlson, A., Manavaki, R., Aigbirhio, F. I., Cheow, H., Buscombe, J. R., Gurnell, M., & Gilbert, F. J. (2016) · Diagnostics · doi:10.3390/diagnostics6040042 · Cited by 36
“Approximately half of all cases of PA are attributable to a unilateral aldosterone-producing adenoma (APA) and, in such cases, adrenalectomy offers the potential for cure of PA and the amelioration/reversal of hypertension [63].”
BackgroundInfluentialRossitto, G., Maiolino, G., Lenzini, L., Bisogni, V., Seccia, T. M., Cesari, M., Iacobone, M., & Rossi, G. P. (2017) · Surgery · doi:10.1016/j.surg.2017.09.032 · Cited by 34
Evaluation of an Adrenal Incidentaloma
Jason, D. S., & Oltmann, S. C. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.009 · Cited by 37
Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses
Yozamp, N., & Vaidya, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101491 · Cited by 33
Perez‐Rivas, L. G., Williams, T. A., & Reincke, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0713-0629 · Cited by 38
“Although the severe comorbidities of affected individuals make the heritability of PASNA very unlikely, it is tempting to speculate that other CACNA1D mutations that cause a milder phenotype could be involved in a still not described familial form of PA, in the same way that has been proposed for KCNJ5 in FH-III.”
BackgroundInfluentialSelf-citationClassification of microadenomas in patients with primary aldosteronism by steroid profiling
Yang, Y., Burrello, J., Burrello, A., Eisenhofer, G., Peitzsch, M., Tetti, M., Knösel, T., Beuschlein, F., Lenders, J. W. M., Mulatero, P., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.008 · Cited by 34
Self-citationEvaluation of bone health in patients with adrenal tumors
Athimulam, S., & Bancos, I. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000478 · Cited by 34
Circulating miRNA Expression Profiling in Primary Aldosteronism
Decmann, Á., Nyírő, G., Darvasi, O., Turai, P. I., Bancos, I., Kaur, R. J., Pezzani, R., Iacobone, M., Kraljević, I., Kaštelan, D., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00739 · Cited by 34
Self-citationPosicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
Yugar‐Toledo, J. C., Moreno, H., Gus, M., Rosito, G. B. A., Scala, L. C. N., Muxfeldt, E. S., Alessi, A., Brandão, A. A., Filho, O. M., Feitosa, A. D. M., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200198 · Cited by 75
Constantinescu, G. A., Langton, K., Conrad, C., Amar, L., Assié, G., Gimenez‐Roqueplo, A., Blanchard, A., Larsen, C. K., Mulatero, P., Williams, T. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa423 · Cited by 33
“Diagnosis was based on results of conventional diagnostic testing following current guidelines (12-14).”
MethodSelf-citationMurck, H., Schlageter, L., Schneider, A., Adolf, C., Heinrich, D. A., Quinkler, M. O., Beuschlein, F., Reincke, M., & Kunzel, H. E. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.006 · Cited by 34
Self-citationDobrowolski, P., Kołodziejczyk‐Kruk, S., Warchoł-Celińska, E., Kabat, M., Ambroziak, U., Wróbel, A., Piekarczyk, P., Ostrowska, A., Januszewicz, M., Śliwiński, P., et al. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8960 · Cited by 35
“We also used in all patients a con fi rmatory test for the diagnosis of PA.”
InfluentialPathophysiology, Evaluation, and Management of Metabolic Alkalosis
Tinawi, M. (2021) · Cureus · doi:10.7759/cureus.12841 · Cited by 33
“Patients suspected of having primary aldosteronism require further testing [34].”
BackgroundDong, H., Zou, Y., He, J., Deng, Y., Chen, Y., Song, L., Xu, B., Gao, R., & Jiang, X. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29554 · Cited by 33
“The diagnosis of IHA was according to the standardized algorithm for the detection, confirmation, and subtype testing of PA according to the criteria of the 2008 Endocrine Society guidelines,11 and all patients underwent computerized tomography and adrenal venous sampling to confirm IHA.12 A lateralization index ≥2 wa…”
BackgroundResultInfluentialGkaniatsa, E., Ekerstad, E., Gavric, M., Muth, A., Trimpou, P., Olsson, D. S., Johannsson, G., & Ragnarsson, Ó. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab327 · Cited by 34
“The median (interquartile range) annual incidence during the whole study period was 6 (2-13) cases per million; 9 (1-17) cases per million for men and 5 (1-11) cases per million for women (P = 0.”
BackgroundInfluentialBuffolo, F., Burrello, J., Burrello, A., Heinrich, D., Adolf, C., Müller, L., Chen, R., Forestiero, V., Sconfienza, E., Tetti, M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17444 · Cited by 37
Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism
Rossi, G. P., Crimì, F., Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Naruse, M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18284 · Cited by 35
“20 Inclusion criteria were (1) age ≥18 years; (2) center’s agreement to participate in the data collection; and (3) approval of the Ethics Committee.”
BackgroundSelf-citationConstantinescu, G. A., Schulze, M., Peitzsch, M., Hofmockel, T., Scholl, U. I., Williams, T. A., Lenders, J. W. M., & Eisenhofer, G. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0470 · Cited by 39
Buffolo, F., Pecori, A., Reincke, M., Outland, M., Veglio, F., Schwarzlmueller, P., Bidlingmaier, M., Kunz, S. L., Stremmel, C., Mengozzi, G., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21983 · Cited by 35
Self-citationTamura, A., Nishimoto, K., Seki, T., Matsuzawa, Y., Saito, J., Omura, M., Gómez-Sánchez, C. E., Makita, K., Matsui, S., Moriya, N., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.031 · Cited by 35
“Briefly, we report a 16-year-old woman with severe PA since the age of 8, diagnosed according to the existing guidelines (Funder et al., 2016; Nishikawa et al., 2011).”
Effects of Treating Primary Aldosteronism on Renal Function
Kramers, B. J., Kramers, C., Lenders, J. W. M., & Deinum, J. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12914 · Cited by 37
“It is treated either by adrenalectomy (ADX) when caused by an aldosterone-producing adenoma (APA) or by mineralocorticoid receptor antagonists (MRAs) in cases of bilateral adrenal hyperplasia.(8) These two treatment modalities lead to similar blood pressure (BP) and renal outcomes.”
Background
Metadata
- Authors
- Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F.
- Affiliations
- Hudson Institute of Medical Research (AU)
- University of Virginia Health System (US)
- University of Padua (IT)
- Mayo Clinic (US)
- Klinikum of the Ludwig-Maximilians-University of Munich (M.R.), 80366 München, Bavaria, Germany
- Oita University (JP)
- The University of Queensland (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-05-01
- Volume
- 101
- Issue
- 5
- Pages
- 1889-1916
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2290633895
- Semantic Scholar
- 36716f26ebd3b8e468f352d9132208c41e5688c0
- Cited by
- 2,925
- References
- 241
- Citations by year
- 2026: 236 · 2025: 397 · 2024: 315 · 2023: 329 · 2022: 329 · 2021: 315 · 2020: 293 · 2019: 238 · 2018: 200 · 2017: 188 · 2016: 72
- FWCI
- 233.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, adrenal computed tomography, adrenal vein sampling, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Adrenal Glands, Adrenalectomy, Aldosterone, Mineralocorticoid Receptor Antagonists, Humans, Hyperaldosteronism, Renin, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.